The Cytel Blog: Perspectives on Enquiry & Evidence

The world's leading supplier of statistical insight to decision-makers in the lifesciences brings you debate and discussion of the newest trends in statistics and quantitative strategy.

March 2, 2021

Hybrid Bayesian and Frequentist Clinical Trial Designs

Most people know that clinical drug discovery is usually conducted using either Frequentist or Bayesian methods. These..

Read article

June 24, 2020

Webinar: Practical Model-based Approaches for Phase I Oncology Trials

Last week, Cytel conducted its third webinar in the new introductory webinar series on Complex Innovative Trial..

Read article

June 15, 2020

Significance of Bayesian Model-Based Approaches in Oncology Trials: An Interview with Dr. Satrajit Roychoudhury

Cytel conducted a webinar with Dr. Satrajit Roychoudhury, Senior Director, Statistical Research and Data Science..

Read article

February 6, 2020

Is your data strategy set up to tackle key challenges in early clinical development?

In clinical development, a high-quality evidence package is a prerequisite for a new therapy to gain approval from..

Read article

|All posts|

The Cytel Blog: Perspectives on Enquiry & Evidence

Hybrid Bayesian and Frequentist Clinical Trial Designs

Webinar: Practical Model-based Approaches for Phase I Oncology Trials

Significance of Bayesian Model-Based Approaches in Oncology Trials: An Interview with Dr. Satrajit Roychoudhury

Is your data strategy set up to tackle key challenges in early clinical development?

Subscribe to our weekly newsletter